Delivery Order SPE2DB22D2009-SPE2DB25FM0XK
- Not listed
- The Defense Logistics Agency awarded a $1,981.11 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This firm fixed-price contract, which must be completed by July 30, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency Troop Support Medical awarded a $168,040 delivery order to Amerisourcebergen Drug Corporation for 20,000 boxes of amoxicillin-clavulanate 875-125 mg tablets. The firm fixed price order is for product delivery to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 27, 2023 in support of DLA's medical supply needs. As a major distributor of pharmaceuticals and medical supplies for the U.S. Department of Defense, this order represents a continuation of...
- The Defense Logistics Agency awarded a $30,691.87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 20 boxes of 875-125 mg amoxicillin-clavulanic acid tablets. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The order is to be completed between August 16 and August 17, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,621 to Amerisourcebergen Drug Corporation to supply 20 tablets of 875-125 mg amoxicillin-clavulanate tablets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to support the Agency's...
- The Defense Logistics Agency awarded a $36,560 delivery order to Amerisourcebergen Drug Corporation for 100 units of 875-125 mg amoxicillin-clavulanate tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Department of Defense health programs. The firm fixed price order has a period of performance from July 5-6, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency routinely...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,032.05 contract is for the delivery of 20-count blister packs of Amox-Clav 875-125 mg tablets. This delivery order falls under an existing $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as a single-award vehicle. The IDC serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,450.00, is for the delivery of Amoxicillin-Clavulanate 500-125 mg tablets in 100-count bottles. The contract is a firm-fixed price type and has a period of performance through March 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The Defense Logistics Agency awarded a $35,586 delivery order to Amerisourcebergen Drug Corporation for 20-count bottles of 875-125 mg amoxicillin-clavulanic acid tablets. Performance will occur in Conshohocken, Pennsylvania under a firm fixed price contract structured for delivery by August 1, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to support the DLA's stockpile of essential medicines for military treatment facilities...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,280 to Amerisourcebergen Drug Corporation for the supply of 100 boxes of 875-125 mg amoxicillin-clavulanic acid tablets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a commonly prescribed antibiotic supports the...
- The Defense Logistics Agency awarded a delivery order valued at thirty-six thousand five hundred sixty dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of eight hundred seventy-five milligrams of amoxicillin and one hundred twenty-five milligrams of clavulanic acid. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania under firm fixed pricing from July fifth through July sixth, twenty twenty-three. No set aside designation...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0XKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,056.72 to AmerisourceBergen Drug Corp for Amoxicillin-Clavulanate 875-125 mg tablets (100 count) on August 14, 2025, with a completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of pharmaceutical products and medical supplies. The company's federal contract awards with DLA demonstrate its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The Pharmaceutical Prime Vendor Global Program under which this order falls represents a strategic approach by DLA to maintain reliable pharmaceutical supply chains for federal healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/14/25 |